JP2002514054A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514054A5
JP2002514054A5 JP1998515028A JP51502898A JP2002514054A5 JP 2002514054 A5 JP2002514054 A5 JP 2002514054A5 JP 1998515028 A JP1998515028 A JP 1998515028A JP 51502898 A JP51502898 A JP 51502898A JP 2002514054 A5 JP2002514054 A5 JP 2002514054A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998515028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514054A (ja
Filing date
Publication date
Priority claimed from US08/716,926 external-priority patent/US6025192A/en
Priority claimed from US08/820,931 external-priority patent/US6255071B1/en
Application filed filed Critical
Publication of JP2002514054A publication Critical patent/JP2002514054A/ja
Publication of JP2002514054A5 publication Critical patent/JP2002514054A5/ja
Ceased legal-status Critical Current

Links

JP51502898A 1996-09-20 1997-09-22 ウイルスベクターおよびそれらの使用 Ceased JP2002514054A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/716,926 1996-09-20
US08/716,926 US6025192A (en) 1996-09-20 1996-09-20 Modified retroviral vectors
US08/820,931 US6255071B1 (en) 1996-09-20 1997-03-19 Mammalian viral vectors and their uses
US08/820,931 1997-03-19
PCT/US1997/017579 WO1998012339A2 (en) 1996-09-20 1997-09-22 Viral vectors and their uses

Publications (2)

Publication Number Publication Date
JP2002514054A JP2002514054A (ja) 2002-05-14
JP2002514054A5 true JP2002514054A5 (enExample) 2005-05-12

Family

ID=27109627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51502898A Ceased JP2002514054A (ja) 1996-09-20 1997-09-22 ウイルスベクターおよびそれらの使用

Country Status (6)

Country Link
US (1) US6255071B1 (enExample)
EP (1) EP0932695A2 (enExample)
JP (1) JP2002514054A (enExample)
AU (1) AU738156B2 (enExample)
IL (1) IL128882A (enExample)
WO (1) WO1998012339A2 (enExample)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69933856D1 (de) 1998-02-13 2006-12-14 Koester Hubert Verwendung von ribozymen zur bestimmung der funktion von genen
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
US20010046669A1 (en) * 1999-02-24 2001-11-29 Mccobmie William R. Genetically filtered shotgun sequencing of complex eukaryotic genomes
JP2002537835A (ja) 1999-03-12 2002-11-12 ジーピーシー バイオテク インコーポレイテッド 合成遺伝子エレメントを同定する方法及び試薬
WO2000055378A1 (en) * 1999-03-16 2000-09-21 Dana-Farber Cancer Institute, Inc. Lentiviral vector system for high quantity screening
AU4559800A (en) * 1999-04-29 2000-11-17 Aarhus Universitet Expression of heterologous genes from an ires translational cassette in retroviral vectors
US20050266544A1 (en) * 1999-04-30 2005-12-01 Human Gene Therapy Research Institute Methods and compositions for increasing viral vector production in packaging cell lines
US7829693B2 (en) * 1999-11-24 2010-11-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
US20030084471A1 (en) 2000-03-16 2003-05-01 David Beach Methods and compositions for RNA interference
AU7025201A (en) * 2000-07-03 2002-01-14 Gala Design Inc Expression vectors
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
US6852510B2 (en) 2000-07-03 2005-02-08 Gala Design Inc Host cells containing multiple integrating vectors
US20040235173A1 (en) * 2000-07-03 2004-11-25 Gala Design, Inc. Production of host cells containing multiple integrating vectors by serial transduction
US20030175972A1 (en) * 2000-10-20 2003-09-18 Daley George Q. Expression vectors and uses thereof
EP1366070A2 (en) 2000-10-25 2003-12-03 Monsanto Technology LLC Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
AU2002246829A1 (en) * 2000-12-22 2002-07-30 The Government Of The United States Of America, Represented By The Secretary, Department Of Health A Methods to control the host range of retroviral vectors
US8546143B2 (en) 2001-01-09 2013-10-01 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
CA2437309A1 (en) * 2001-02-05 2002-08-15 Minos Biosystems Limited Insertional mutagenesis technique
US20030082140A1 (en) * 2001-08-20 2003-05-01 Fisher Paul B. Combinatorial methods for inducing cancer cell death
US20030054354A1 (en) * 2001-08-23 2003-03-20 Bennett C. Frank Use of antisense oligonucleotide libraries for identifying gene function
US20030050266A1 (en) * 2001-09-07 2003-03-13 Fisher Paul B. Anti-tumor effects of prostate carcinoma tumor antigen-1
US7195916B2 (en) * 2001-09-13 2007-03-27 California Institute Of Technology Method for expression of small antiviral RNA molecules within a cell
US7732193B2 (en) 2001-09-13 2010-06-08 California Institute Of Technology Method for expression of small RNA molecules within a cell
US7737124B2 (en) 2001-09-13 2010-06-15 California Institute Of Technology Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
US20040038304A1 (en) * 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
US7384738B2 (en) * 2002-03-28 2008-06-10 Bremel Robert D Retrovirus-based genomic screening
WO2003104415A2 (en) * 2002-06-05 2003-12-18 Sopherion Therapeutics, Inc. Method to screen ligands using eukaryotic cell display
EP1912069A3 (en) 2002-06-05 2008-07-09 Sopherion Therapeutics, Inc. Method to screen ligands using eukaryotic cell display
NZ562736A (en) 2002-08-21 2009-07-31 Revivicor Inc Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
US20040052161A1 (en) * 2002-09-17 2004-03-18 Steven Liao Mechanical clock having wireless manipulation and adjustment function
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
WO2004106488A2 (en) * 2003-05-12 2004-12-09 Potomac Pharmaceuticals, Inc. Gene expression suppression agents
US20050064547A1 (en) * 2003-09-24 2005-03-24 Brown Arthur M. Vectors and transfected cells
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
CA2543257C (en) 2003-10-24 2013-12-31 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
US8053232B2 (en) 2004-01-23 2011-11-08 Virxsys Corporation Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
CA2554209A1 (en) * 2004-02-05 2005-10-27 Massachusetts Institute Of Technology Cell display libraries
EP2412816B1 (en) 2004-07-26 2014-12-03 Pfenex Inc. Process for improved protein expression by strain engineering
US20080026410A1 (en) * 2004-12-02 2008-01-31 Antonia Vlahou Biomarkers for Bladder Cancer
US20060183893A1 (en) * 2005-01-25 2006-08-17 North Don A Nucleic acids for apoptosis of cancer cells
KR20070095452A (ko) * 2005-01-25 2007-09-28 스카이 제네틱스, 인코포레이티드 암 세포의 세포자멸사를 위한 핵산
US7790446B2 (en) * 2005-02-11 2010-09-07 Kosagen Cell Factory Oü Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
US8377653B2 (en) * 2005-02-11 2013-02-19 Icosagen Cell Factory Oü Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays
EP1874936B1 (en) 2005-04-19 2013-10-30 BASF Plant Science GmbH Improved methods controlling gene expression
WO2006128084A2 (en) * 2005-05-27 2006-11-30 The Trustees Of Columbia University In The City Of New York Trps1-mediated modulation of hair growth
WO2006128085A2 (en) * 2005-05-27 2006-11-30 The Trustees Of Columbia University In The City Of New York Cadherin-11-mediated modulation of hair growth
NZ565711A (en) 2005-08-09 2011-10-28 Revivicor Inc Transgenic ungulates expressing a porcine CTLA4 peptide fused to an immunoglobulin
CA2620387C (en) 2005-09-20 2018-09-18 Basf Plant Science Gmbh Methods for controlling gene expression using ta-sirna
US8278104B2 (en) * 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
ZA200804673B (en) * 2005-12-13 2009-11-25 Univ Kyoto Nuclear reprogramming factor
US8129187B2 (en) * 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
WO2007121054A2 (en) * 2006-03-27 2007-10-25 Sky Genetics, Inc. Nucleic acids for apoptosis of cancer cells
US8252527B2 (en) * 2007-02-16 2012-08-28 The Research Foundation Of State University Of New York Method for identification of polynucleotides capable of cleaving target mRNA sequences
CA2685326A1 (en) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
KR101445903B1 (ko) 2007-05-02 2014-09-29 메리얼 리미티드 향상된 발현 및 안정성을 갖는 dna 플라스미드
JP2008307007A (ja) * 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US9213999B2 (en) * 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
US20100279404A1 (en) 2008-05-02 2010-11-04 Shinya Yamanaka Method of nuclear reprogramming
WO2010006415A1 (en) * 2008-06-30 2010-01-21 Atgcell Inc. Mammalian cell expression vectors and utilization
WO2010127209A2 (en) 2009-04-30 2010-11-04 The Research Foundation Of State University Of New York Compositions and methods for therapy of macular degeneration
JP5756247B1 (ja) 2012-05-08 2015-07-29 アダプティブ バイオテクノロジーズ コーポレイション マルチプレックスpcr反応における増幅バイアスを測定し校正する組成物及び方法
DK2986635T3 (en) * 2013-04-18 2019-01-28 Fond Telethon EFFECTIVE DELIVERY OF BIG GENES THROUGH DUAL-AAV VECTORS
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
AU2015339191A1 (en) 2014-10-29 2017-05-18 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
GB201603372D0 (en) * 2016-02-26 2016-04-13 Ucl Business Plc Cell
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
WO2018232079A1 (en) 2017-06-14 2018-12-20 Daley George Q Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
CN114269938A (zh) * 2019-06-21 2022-04-01 阿斯克肋匹奥生物制药公司 使用噬菌体复制起点生产载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5378618A (en) 1988-04-15 1995-01-03 E. I. Du Pont De Nemours And Company Vitro headful packaging system for cloning DNA fragments as large as 95kb
WO1991010728A1 (en) 1990-01-19 1991-07-25 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Novel retroviral vectors

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000514473A5 (enExample)
JP2000501599A5 (enExample)
JP2000500076A5 (enExample)
JP2002514054A5 (enExample)
JP2000500055A5 (enExample)
JP2001506735A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2001506386A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)
JP2001501170A5 (enExample)
JP2000502714A5 (enExample)
JP2000500184A5 (enExample)
JP2000500318A5 (enExample)